Incyte | INCY - 销售毛利

股票价格
99.14
每天变化
1.40 1.43%
每月一次
9.75%
每年
58.22%
Q2 预测
92.62


金融业
股票价格
USD
资产
USD 7.34B
现金及等价物
USD 4.02B
销售成本
USD 121.18M
流动资产
USD 5.48B
流动负债
USD 1.49B
债务
USD 40.41M
EBIT
USD 383.88M
EBITDA
USD 414.51M
员工
2.62K
EPS每股收益
USD 1.81
股本和储备
USD 5.62B
销售毛利
USD 1.17B
债务利息支出
USD 569K
利息收入
USD 30.75M
贷款资金
USD 29.41M
市值
USD 22.13B
净收入
USD 299.28M
营业费用
USD 5.62B
营业利润
USD 383.88M
普通股股本
USD 199.95M
PE价格收益
15.35
税前利润
USD 389.94M
销售收入
USD 1.27B
销售和管理费用
USD 390.41M
股票
USD 115.62M
贸易债权人
USD 228.62M
应收帐款人
USD 1.05B


销售毛利 更改 日
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
Agenus USD 34.2M 4.61M 2025-12
Agios Pharmaceuticals USD 18.09M 6.89M 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Amgen USD 6.48B 307M 2025-09
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Eli Lilly USD 14.59B 1.48B 2025-09
Exelixis USD 572.18M 7M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
Incyte USD 1.17B 217.51M 2026-03
Ionis Pharmaceuticals USD 243M 48M 2026-03
MacroGenics USD 31.11M 30.14M 2025-12
Merck USD 13.42B 431M 2025-09
Moderna USD 226M 583M 2025-12
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Neurocrine Biosciences USD 787.9M 7M 2025-12
Novartis USD 10.25B 570M 2025-12
Novartis USD 10.82B 694M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
PTC Therapeutics USD 148.38M 39.31M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12